Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, Murat, Aarsland, Dag, Brown, Richard, Burn, David J., Duyckaerts, Charles, Mizuno, Yoshikino, Broe, Gerald Anthony, Cummings, Jeffrey +15 more·2007·Movement Disorders

DOI 10.1002/mds.21507

Cited by (1,006)

Items 601–700 of 1,006

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
María Teresa Cáceres‐Redondo, Fátima Carrillo, María J. Lama, Ismael Huertas‐Fernández, Laura Vargas‐González, Manuel Carballo, Pablo Mir · 2014 · Journal of Neurology
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease
Roberta Biundo, Luca Weis, Manuela Pilleri, Silvia Facchini, Patrizia Formento‐Dojot, Annamaria Vallelunga, Angelo Antonini · 2013 · Journal of Neural Transmission
Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies
Akira Kurita, Maiko Murakami, Satoshi Takagi, Masato Matsushima, Masahiko Suzuki · 2010 · Movement Disorders
Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients
Lucie Plomhause, Kathy Dujardin, Alain Duhamel, Marie Delliaux, Philippe Derambure, Luc Defebvre, C. Monaca Charley · 2013 · Sleep Medicine
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
Jennifer G. Goldman, Glenn T. Stebbins, Bryan A. Bernard, Travis R. Stoub, Christopher G. Goetz, Leyla deToledo‐Morrell · 2012 · Movement Disorders
Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers
María Victoria Navarta Sánchez, Juana María Senosiain García, Mario Riverol, María Eugenia Ursúa Sesma, Sara Díaz de Cerio Ayesa, Sagrario Anaut Bravo, Neus Caparrós Civera, Mari Carmen Portillo · 2016 · Quality of Life Research
Initial cognitive changes in Parkinson's disease
Daniel A. Weintraub, Alexander I. Tröster, Connie Marras, Glenn T. Stebbins · 2018 · Movement Disorders
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
Jennifer G. Goldman, Leah K. Forsberg, Bradley F. Boeve, Melissa J. Armstrong, David John Irwin, Tanis J. Ferman, Doug R. Galasko, James E. Galvin, Daniel Kaufer, James B. Leverenz et al. · 2020 · Alzheimer s Research & Therapy
Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?
Jellinger, Kurt A. · 2009 · Acta Neuropathologica
Brain metabolic abnormalities during gait with freezing in Parkinson’s disease
Céline Tard, Arnaud Delval, David Devos, Renaud Lopes, Pierre Lenfant, Kathy Dujardin, Claude Hossein-Foucher, Franck Semah, A. Duhamel, Luc Defebvre et al. · 2015 · Neuroscience
Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease
Mario Ezquerra, Jaume Campdelacreu, Carles Gaig, Yaroslau Compta, Esteban Muñoz, Marı́a José Martı́, Francesc Valldeoriola, EDUARDO S. TOLOSA · 2008 · Neuroscience Letters
Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases
Steven Edward Arnold, Jon B. Toledo, Dina H. Appleby, Sharon Xiangwen Xie, Weixin Wang, Young Baek, David A. Wolk, Edward B. Lee, Bruce L. Miller, Virginia M.‐Y. Lee et al. · 2013 · The Journal of Comparative Neurology
Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status
Jaeseung Shin, Sung‐Eun Choi, Ji E. Lee, Hye Sun Lee, Young H. Sohn, Phil Hyu Lee · 2012 · Journal of Neurology Neurosurgery & Psychiatry
Cognitive Characteristics Associated with Mild Cognitive Impairment in Parkinson’s Disease
Audrey McKinlay, Randolph C. Grace, John C. Dalrymple‐Alford, Derek Roger · 2009 · Dementia and Geriatric Cognitive Disorders
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders
Alessandro Tessitore, Gabriella Santangelo, Rosa De Micco, Alfonso Giordano, Simona Raimo, Marianna Amboni, Fabrizio Esposito, Paolo Barone, Gioacchino Tedeschi, Carmine Vitale · 2017 · Cortex
REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
Po-Chi Chan, Hsun‐Hua Lee, Chien‐Tai Hong, Chaur‐Jong Hu, Dean Wu · 2018 · Behavioural Neurology
Executive dysfunction in Parkinson’s disease: A meta-analysis on the Wisconsin Card Sorting Test literature
Florian Lange, Carolin Brückner, Aylin Knebel, Caroline Seer, Bruno Kopp · 2018 · Neuroscience & Biobehavioral Reviews
Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
Chin‐Hsien Lin, Shu-I Chiu, Ta‐Fu Chen, Jyh‐Shing Roger Jang, Ming‐Jang Chiu · 2020 · International Journal of Molecular Sciences
Risk of Parkinson's disease dementia related to level I MDS PD‐MCI
Jeroen Hoogland, Judith A. Boel, Rob M. A. de Bie, Ben A. Schmand, Ronald Bertus Geskus, John C. Dalrymple‐Alford, Connie Marras, Charles H. Adler, Daniel A. Weintraub, Carme Junqué et al. · 2019 · Movement Disorders
The temporal onset of the core features in dementia with Lewy bodies
Parichita Choudhury, Jonathan Graff‐Radford, Jeremiah A. Aakre, Lincoln I. Wurtz, David S. Knopman, Neill R. Graff‐Radford, Kejal Kantarci, Leah K. Forsberg, Julie A. Fields, Otto Pedraza et al. · 2021 · Alzheimer s & Dementia
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
Mahsa Dadar, Sawsan Mahmoud, Maryna Zhernovaia, Richard M. Camicioli, Josefina Maranzano, Simon Duchesne, For the CCNA Group · 2022 · NeuroImage Clinical
Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study
Friederike Fritze, Uwe Ehrt, Tibor Hortobágyi, Clive G. Ballard, Dag Aarsland · 2011 · Dementia and Geriatric Cognitive Disorders
Gray matter atrophy in Parkinson’s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies
Ping Lei Pan, Hai Cun Shi, Jian Guo Zhong, Pei Rong Xiao, Yuan Shen, Li Wu, Yuan Ying Song, Gui Xiang He, Hua Liang Li · 2012 · Neurological Sciences
Quantitative EEG Analysis of Executive Dysfunction in Parkinson Disease
Satoshi Kamei, Akihiko Morita, Kan Serizawa, Tomohiko Mizutani, Kaname Hirayanagi · 2010 · Journal of Clinical Neurophysiology
Risk of dementia in an elderly population of Parkinson's disease patients: A 15‐year population‐based study
Florian Perez, Catherine Helmer, Alexandra Foubert‐Samier, Sophie Auriacombe, Jean‐François Dartigues, François Tison · 2012 · Alzheimer s & Dementia
A randomized trial of individual versus group-format exercise and self-management in individuals with Parkinson’s disease and comorbid depression
Martha Sajatovic, Angela L. Ridgel, Ellen M. Walter, Curtis M. Tatsuoka, Kari Colón-Zimmermann, Riane K. Ramsey, Elisabeth Welter, Steven A. Gunzler, Christina M. Whitney, Benjamin L. Walter · 2017 · Patient Preference and Adherence
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
Giovanni Bellomo, Antonio Indaco, Davide Chiasserini, Emanuela Maderna, Federico Paolini Paoletti, Lorenzo Gaetani, Silvia Paciotti, Maya Petricciuolo, Fabrizio Tagliavini, Giorgio Giaccone et al. · 2021 · Frontiers in Neuroscience
Gut microbiota in dementia with Lewy bodies
Hiroshi Nishiwaki, Jun Ueyama, Kenichi Kashihara, Mikako Ito, Tomonari Hamaguchi, Tetsuya Maeda, Yoshio Tsuboi, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno · 2022 · npj Parkinson s Disease
Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes
Chiara Cappelletti, Sandra Pilar Henriksen, Hanneke Geut, Annemieke J.M. Rozemüller, Wilma D. J. van de Berg, Lasse Pihlstrøm, Mathias Toft · 2023 · Acta Neuropathologica
A Validation Study of the Japanese Version of the Addenbrooke’s Cognitive Examination-Revised
Kelssy Hitomi dos Santos Kawata, Ryusaku Hashimoto, Yoshiyuki Nishio, Atsuko Hayashi, Nanayo Ogawa, Shigenori Kanno, Kotaro Hiraoka, Kayoko Yokoi, Osamu Iizuka, Etsuro Mori · 2012 · Dementia and Geriatric Cognitive Disorders Extra
Dysexecutive disorders and their diagnosis: A position paper
Olivier Godefroy, Olivier Martinaud, Pauline Narme, Pierre‐Alain Joseph, Chrystèle Mosca, Eugénie Lhommée, Thierry Meulemans, Virginie Czernecki, Céline Bertola, Pierre M. Labauge et al. · 2018 · Cortex
Using Kinect to classify Parkinson’s disease stages related to severity of gait impairment
Lacramioara Dranca, Lopez de Abetxuko Ruiz de Mendarozketa, Alfredo Goñi, Arantza Illarramendi, Irene Navalpotro‐Gómez, Manuel Delgado‐Alvarado, María Rodríguez‐Oroz · 2018 · BMC Bioinformatics
Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment
Seok Jong Chung, Han Soo Yoo, Yang Hyun Lee, Hye Sun Lee, Byoung Seok Ye, Young H. Sohn, Hunki Kwon, Phil Hyu Lee · 2019 · Human Brain Mapping
Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
Jacob D. Jones, Taylor P. Kuhn, Sarah M. Szymkowicz · 2017 · Parkinsonism & Related Disorders
Sleep disturbances in Lewy body dementia: A systematic review
Greg J. Elder, Alpár S. Lázár, Pamela Alfonso‐Miller, John‐Paul Taylor · 2022 · International Journal of Geriatric Psychiatry
Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
Per Borghammer, Niels Okkels, Daniel A. Weintraub · 2024 · Journal of Parkinson s Disease
Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
Magdalena Nutu, Henrik Zetterberg, Elisabet Londos, Lennart Minthon, Katarina Nägga, Kaj Blennow, Oskar Hansson, Annika Öhrfelt · 2013 · Dementia and Geriatric Cognitive Disorders
Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
Hana Přikrylová Vranová, Eva Hényková, Michaela Kaiserová, Kateřina Menšíková, Miroslav Vaštík, Jan Mareš, Petr Hluštı́k, Jana Zapletalová, Miroslav Strnad, David Stejskal et al. · 2014 · Journal of the Neurological Sciences
Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease
Han‐Joon Kim, Beom S. Jeon, Sun Ha Paek, Kyoungmin Lee, Ji-Young Kim, Jee‐Young Lee, Hee Jin Kim, Ji Young Yun, Young Eun Kim, Hui Jun Yang et al. · 2014 · Journal of Neurology
Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients
Roberta Biundo, Massimiliano Calabrese, Luca Weis, Silvia Facchini, Gianluigi Ricchieri, Paolo Gallo, Angelo Antonini · 2013 · PLoS ONE
Neurobiology of cognitive impairment in Parkinson’s disease
K. A. Jellinger · 2012 · Expert Review of Neurotherapeutics
Vascular Risk Factors and Cognition in Parkinson’s Disease
Andrea Pilotto, Rosanna Turrone, Inga Liepelt‐Scarfone, Marta Bianchi, Loris Poli, Barbara Borroni, Antonella Alberici, Enrico Premi, Anna Formenti, Barbara Bigni et al. · 2016 · Journal of Alzheimer s Disease
Non-demented Parkinson’s disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes
Saül Martínez‐Horta, Frederic Sampedro, Javier Pagonabarraga, Ramón Fernández de Bobadilla, Juan Marín‐Lahoz, Jordi Riba A, Jaime Kulisevsky · 2016 · Brain Imaging and Behavior
Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.
Eva Pirogovsky-Turk, Raeanne C. Moore, J. Filoteo, I. Litvan, D. Song, S. Lessig, D. Schiehser · 2017 · The American journal of geriatric psychiatry
Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study
Jennifer Y. Y. Szeto, Courtney Campbell Walton, Alexandra Rizos, Pablo Martínez‐Martín, Glenda Margaret Halliday, Sharon Linda Naismith, К. Ray Chaudhuri, Simon J.G. Lewis · 2020 · npj Parkinson s Disease
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?
Rachael Purri, Laura Brennan, Jacqueline H. Rick, Sharon Xiangwen Xie, Benjamin L. Deck, Lana M. Chahine, Nabila A. Dahodwala, Alice S. Chen‐Plotkin, John E. Duda, James F. Morley et al. · 2020 · Movement Disorders
Functional and structural brain network correlates of visual hallucinations in Lewy body dementia
Ramtin Mehraram, Luis R. Peraza, Nicholas Murphy, Ruth A. Cromarty, Sara Graziadio, John Tiernan O'Brien, Alison Killen, Sean J. Colloby, Michael Firbank, Li Su et al. · 2022 · Brain
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
Hiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson et al. · 2022 · Acta Neuropathologica Communications
The genetic regulation of protein expression in cerebrospinal fluid
Hansson, Oskar, Kumar, Atul, Janelidze, Shorena, Stomrud, Erik, Insel, Philip S, Blennow, Kaj, Zetterberg, Henrik, Fauman, Eric, Hedman, Åsa K, Nagle, Michael W et al. · 2023 · EMBO Molecular Medicine
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis
Ruth Chia, Ruin Moaddel, Justin Y. Kwan, Memoona Rasheed, Paola Ruffo, Natalie Landeck, Paolo Reho, Rosario Vasta, Andrea Calvo, Cristina Moglia et al. · 2025 · Nature Medicine
Neurophysiological biomarkers for Lewy body dementias
Ruth A. Cromarty, Greg J. Elder, Sara Graziadio, Mark R. Baker, Laura Bonanni, MARCO C. ONOFRJ, John Tiernan O'Brien, John‐Paul Taylor · 2015 · Clinical Neurophysiology
Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia
Evelyne Matteau, Nicolas Dupré, Mélanie Langlois, Pierre Provencher, Martine Simard · 2012 · Journal of Geriatric Psychiatry and Neurology
Evolution of the diagnostic criteria for degenerative and cognitive disorders
Oscar L. López, Eric McDade, Mario Riverol, James T. Becker · 2011 · Current Opinion in Neurology
Multivariate classification of patients with Alzheimer’s and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study
Alexander V. Lebedev, Eric Westman, Mona Kristiansen Beyer, Milica Gregorič Kramberger, Carlos Aguilar, Zvezdan Pirtošek, Dag Aarsland · 2012 · Journal of Neurology
Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study
Aleksander Hagen Erga, Guido Werner Alves, Jan Petter Larsen, Ole‐Bjørn Tysnes, Kenn Freddy Pedersen · 2016 · Journal of Parkinson s Disease
Goal‐orientated cognitive rehabilitation for dementias associated with Parkinson's disease―A pilot randomised controlled trial
John Vincent Hindle, Tamlyn Watermeyer, Julie Roberts, Andrew Brand, Zoë Hoare, Anthony Martyr, Linda Clare · 2018 · International Journal of Geriatric Psychiatry
Brain degeneration in Parkinson’s disease patients with cognitive decline: a coordinate-based meta-analysis
Alexander S. Mihaescu, Mario Masellis, Ariel Graff‐Guerrero, Jinhee Kim, Marion Criaud, Sang Soo Cho, Christine Ghadery, Mikaeel Valli, Antonio P. Strafella · 2018 · Brain Imaging and Behavior
Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson’s Disease
Caroline Xie, Asheeta A. Prasad · 2020 · Microorganisms
Psychiatric issues in cognitive impairment
Dag Aarsland, John‐Paul Taylor, Daniel A. Weintraub · 2014 · Movement Disorders
The effects of Mediterranean diet on severity of disease and serum Total Antioxidant Capacity (TAC) in patients with Parkinson’s disease: a single center, randomized controlled trial
Zamzam Paknahad, Elham Sheklabadi, Amir Reza Moravejolahkami, Ahmad Chitsaz, Akbar Hassanzadeh · 2020 · Nutritional Neuroscience
Multivariate prediction of dementia in Parkinson’s disease
Thanaphong Phongpreecha, Brenna Cholerton, Ignacio Fernandez Mata, Cyrus P. Zabetian, Kathleen L. Poston, Nima Aghaeepour, Lü Tian, Joseph F. Quinn, Kathryn A. Chung, Amie Hiller et al. · 2020 · npj Parkinson s Disease
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Carceles‐Cordon, Dan Weintraub, Alice S. Chen‐Plotkin · 2023 · Neuron
Non-motor features of Parkinson's disease: depression and dementia
Heinz Reichmann, Christine B. Schneider, Matthias Löhle · 2009 · Parkinsonism & Related Disorders
The Impact of MRI White Matter Hyperintensities on Dementia in Parkinson's Disease in Relation to the Homocysteine Level and Other Vascular Risk Factors
Jarosław W. Sławek, Anna Roszmann, Piotr Robowski, Mirosława Dubaniewicz, Emilia Jadwiga Sitek, Krystyna Honczarenko, Agnieszka Gorzkowska, Sławomir P Budrewicz, Monika Mak, Monika Gołąb-Janowska et al. · 2012 · Neurodegenerative Diseases
Understanding facial emotion perception in Parkinson's disease: The role of configural processing
Pauline Narme, Anne-Marie Bonnet, Bruno Dubois, Laurence Chaby · 2011 · Neuropsychologia
Cognitive disorders in Parkinson's disease: Confirmation of a spectrum of severity
Kathy Dujardin, Anja J.H. Moonen, Hélène Béhal, Luc Defebvre, Alain Duhamel, Annelien Duits, Lucie Plomhause, Céline Tard, Albert F.G. Leentjens · 2015 · Parkinsonism & Related Disorders
Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)
Jaime Kulisevsky, M. R. Luquín, José Matías Arbelo, Juan Andrés Burguera, F. Carrillo, A. Castro, J. Chacón, Pedro Ruiz, E. Lezcano, Pablo Mir et al. · 2013 · Neurología (English Edition)
Executive attention networks show altered relationship with default mode network in PD
Peter Boord, Tara M. Madhyastha, Mary K. Askren, Thomas J. Grabowski · 2016 · NeuroImage Clinical
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
Hazel Hall‐Roberts, Bernard Laurent Schneider, David R. Brown · 2017 · PLoS ONE
Exploring the Role of Cognitive Factors in a New Instrument for Elders’ Financial Capacity Assessment
Vaitsa Giannouli, Dimitrios Stamovlasis, Magda Tsolaki · 2018 · Journal of Alzheimer s Disease
Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
Linda Haertner, Morad Elshehabi, Laura Zaunbrecher, Minh Hoang Pham, Corina Maetzler, Janet M.T. van Uem, Markus A. Hobert, Svenja Hucker, Susanne Nussbaum, Daniela Berg et al. · 2018 · Frontiers in Aging Neuroscience
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18F‐FDG PET imaging
Lei Wu, Fengtao Liu, Jingjie Ge, Jue Zhao, Yilin Tang, Wenbo Yu, Huan Yu, Tim Anderson, Chuantao Zuo, Ling Chen et al. · 2018 · Human Brain Mapping
A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment
Ignacio Aracil‐Bolaños, Frederic Sampedro, Juan Marín‐Lahoz, Andrea Horta‐Barba, Saül Martínez‐Horta, Maria Angeles Boti, Jesús Pérez‐Pérez, Helena Bejr‐Kasem, Berta Pascual‐Sedano, Antònia Campolongo et al. · 2019 · Human Brain Mapping
Parkinson's and Lewy body dementia CSF biomarkers
Lucilla Parnetti, Silvia Paciotti, Lucia Farotti, Giovanni Bellomo, Federica Nicoletta Sepe, Paolo Eusebi · 2019 · Clinica Chimica Acta
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease
A. Zarkali, P. McColgan, Louise-Ann Leyland, A. Lees, R. Weil · 2020 · bioRxiv
Lewy body dementia and Parkinson’s disease with dementia
Richard C. Dodel, Ilona Csóti, Georg Ebersbach, G. Fuchs, Matthias Hahne, Wilfried Kuhn, Matthias Oechsner, Wolfgang H. Jost, Heinz Reichmann, Jörg Bernhard Schulz · 2008 · Journal of Neurology
Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences
Luis R. Peraza, Sean J. Colloby, Michael Firbank, G. Shirmin Greasy, Ian Grant McKeith, Marcus Kaiser, John Tiernan O'Brien, John‐Paul Taylor · 2015 · International Journal of Geriatric Psychiatry
Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease
Eva Christina Schulte, Akio Fukumori, Brit Mollenhauer, Hyun Hor, Thomas Arzberger, Robert Perneczky, Alexander Kurz, Janine Diehl‐Schmid, Michael Hüll, Peter Lichtner et al. · 2015 · European Journal of Human Genetics
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Monika Balzer‐Geldsetzer, Ana Sofia Costa, Martin Kronenbürger, Jörg Bernhard Schulz, Sandra Röske, Annika E. Spottke, Ullrich Wüllner, Thomas Klockgether, Alexander Storch, Christine B. Schneider et al. · 2011 · Neuroepidemiology
Prevalence of Dementia in the Rural Island Town of Ama-cho, Japan
Kenji Wada‐Isoe, Yusuke Uemura, Yutaka Suto, Koji Doi, Keiko Imamura, Ai Hayashi, Michio Kitayama, Yasuhiro Watanabe, Yoshiki Adachi, Kenji Nakashima · 2008 · Neuroepidemiology
A Précis of Recent Advances in the Neuropsychology of Mild Cognitive Impairment(s) in Parkinson's Disease and a Proposal of Preliminary Research Criteria
Alexander I. Tröster · 2011 · Journal of the International Neuropsychological Society
Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study.
Alexander V. Lebedev, M. Beyer, F. Fritze, E. Westman, C. Ballard, D. Aarsland · 2014 · The American journal of geriatric psychiatry
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment
Carmen Gasca‐Salas, Pedro Clavero, David García‐García, Jose Angel Obeso, María Rodríguez‐Oroz · 2015 · Human Brain Mapping
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies
Stephen N. Gomperts, Marta Marquié, Joseph J. Locascio, Stephen Bayer, Keith A. Johnson, John H. Growdon · 2015 · Neurodegenerative Diseases
Death certificate data and causes of death in patients with parkinsonism
Mariana Moscovich, Gabriela Boschetti, Adriana Moro, Hélio Afonso Ghizoni Teive, Anhar Hassan, Renato P. Munhoz · 2017 · Parkinsonism & Related Disorders
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger · 2019 · Journal of Neural Transmission
Fluctuating cognition in the Lewy body dementias
Seán O’Dowd, Julia Schumacher, David John Burn, Laura Bonanni, MARCO C. ONOFRJ, Alan J. Thomas, John‐Paul Taylor · 2019 · Brain
Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease
Mi Sun Sung, Seong‐Min Choi, Jong-Hwa Kim, Jun Young Ha, Byeong Chae Kim, Hwan Heo, Sang Woo Park · 2019 · Scientific Reports
Patterns of striatal dopamine depletion in early Parkinson disease
Seok Jong Chung, Hye Sun Lee, Han Soo Yoo, Yang Hyun Lee, Phil Hyu Lee, Young H. Sohn · 2020 · Neurology
Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson disease
Alessandra Fanciulli, Nicole Campese, Georg Goebel, Jean Pierre Ndayisaba, Sabine Eschlboeck, Christine Kaindlstorfer, Cecilia Raccagni, Roberta Granata, Ubaldo Bonuccelli, Roberto Ceravolo et al. · 2020 · Neurology
Widespread cortical and subcortical brain atrophy in Parkinson’s disease with excessive daytime sleepiness
S. Kato, Hirohisa Watanabe, Joe Senda, Masaaki Hirayama, Mizuki Ito, Naoki Atsuta, Tomotsugu Kaga, Masahisa Katsuno, Shinji Naganawa, Gen Sobue · 2011 · Journal of Neurology
Cognitive performance and electrophysiological indices of cognitive control: A validation study of conflict adaptation
Peter Eugene Clayson, Michael J. Larson · 2012 · Psychophysiology
Systems biology of neurodegenerative diseases
Levi Benjamin Wood, Ashley R. Winslow, Samantha Dale Strasser · 2015 · Integrative Biology
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients
Maria Teresa Pellecchia, Gabriella Santangelo, Marina Picillo, Rosario Pivonello, Katia Longo, Claudia Pivonello, Carmine Vitale, Marianna Amboni, Anna De Rosa, Marcello Moccia et al. · 2012 · Journal of Neurology
Prevalence of Dementia and Mild Cognitive Impairment in the Rural Island Town of Ama-cho, Japan
Kenji Wada‐Isoe, Yusuke Uemura, Satoko Nakashita, Mika Yamawaki, Ken‐ichiro Tanaka, Mikie Yamamoto, Hiroshi Shimokata, Kenji Nakashima · 2012 · Dementia and Geriatric Cognitive Disorders Extra
Mild cognitive impairment in Parkinson’s disease
Saül Martínez‐Horta, Jaime Kulisevsky · 2019 · Journal of Neural Transmission
Development and external validation of a prognostic model in newly diagnosed Parkinson disease
D. Velseboer, R. D. de Bie, L. Wieske, J. Evans, S. Mason, T. Foltynie, B. Schmand, R. de Haan, B. Post, R. Barker et al. · 2016 · Neurology
Using Cerebrospinal Fluid Marker Profiles in Clinical Diagnosis of Dementia with Lewy Bodies, Parkinson's Disease, and Alzheimer's Disease
Lisa Kaerst, Andre Kuhlmann, D. Wedekind, K. Stoeck, P. Lange, I. Zerr · 2013 · Journal of Alzheimer's Disease
Treatment of early Parkinson's disease
Rajesh Pahwa, Kelly E. Lyons · 2014 · Current Opinion in Neurology
Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
Yaroslau Compta, Naroa Ibarretxe‐Bilbao, Joana B. Pereira, Carme Junqué, Núria Bargalló, EDUARDO S. TOLOSA, Francesc Valldeoriola, Esteban Muñoz, Ana Cámara, Maríateresa Buongiorno et al. · 2012 · Parkinsonism & Related Disorders